PMID- 34467577 OWN - NLM STAT- MEDLINE DCOM- 20211224 LR - 20221207 IS - 1099-1573 (Electronic) IS - 0951-418X (Linking) VI - 35 IP - 12 DP - 2021 Dec TI - The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. PG - 6802-6812 LID - 10.1002/ptr.7265 [doi] AB - This systematic review and meta-analysis aims to find the effect of Gymnema sylvestre (GS) supplementation on glycemic control in type-2 diabetes mellitus (T2DM). PubMed, Cochrane library, Google Scholar, and Science Direct were searched from inception to June 2020 to identify the studies that reported GS supplementation on glycemic parameters. Standardized mean difference (SMD) was calculated by comparing the post-intervention data with baseline data. SMDs with 95% confidence intervals (CIs) were pooled using a random-effects model. Our meta-analysis consisting of 10 studies with a total of 419 participants showed that GS supplementation significantly reduces fasting blood glucose (FBG) (SMD 1.57 mg/dl, 95% CI 2.22 to -0.93, p < .0001, I(2) 90%), postprandial blood glucose (PPBG) (SMD 1.04 mg/dl, 95% CI 1.53 to -0.54, p < .0001, I(2) 80%), and glycated haemoglobin (HbA1c) (SMD 3.91, 95% CI 7.35 to -0.16%, p < .0001, I(2) 99%) compared to baseline. Further, our study also found that GS significantly reduces triglycerides (SMD 1.81 mg/dl, 95% CI 2.95 to -0.66, p < .0001, I(2) : 96%), and total cholesterol (SMD 4.10 mg/dl, 95% CI 7.21 to -0.99, p < .0001, I(2) : 98%) compared to baseline. Our study shows that GS supplementation is effective in improving glycemic control and reducing lipid levels in T2DM patients and suggests that such supplementation might be used as an effective therapy for the management of T2DM and its associated complications to an extent. CI - (c) 2021 John Wiley & Sons Ltd. FAU - Devangan, Suneel AU - Devangan S AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Guwahati, Guwahati, Assam, India. AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Hajipur, Hajipur, Bihar, India. FAU - Varghese, Bincy AU - Varghese B AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Guwahati, Guwahati, Assam, India. FAU - Johny, Ebin AU - Johny E AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Guwahati, Guwahati, Assam, India. FAU - Gurram, Surender AU - Gurram S AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Guwahati, Guwahati, Assam, India. FAU - Adela, Ramu AU - Adela R AUID- ORCID: 0000-0003-0909-2557 AD - Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research-Guwahati, Guwahati, Assam, India. LA - eng GR - Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Govt. of India/ GR - NIPER-Guwahati/ GR - Institutional Core Grant/ PT - Journal Article PT - Meta-Analysis PT - Review PT - Systematic Review DEP - 20210901 PL - England TA - Phytother Res JT - Phytotherapy research : PTR JID - 8904486 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) SB - IM MH - Blood Glucose MH - *Diabetes Mellitus, Type 2/drug therapy MH - Dietary Supplements MH - Glycated Hemoglobin/analysis MH - Glycemic Control MH - *Gymnema sylvestre MH - Humans OTO - NOTNLM OT - Gymnema sylvestre OT - glycemic control OT - lipid profile OT - meta-analysis OT - systematic review OT - type-2 DM EDAT- 2021/09/02 06:00 MHDA- 2021/12/25 06:00 CRDT- 2021/09/01 07:43 PHST- 2021/06/15 00:00 [revised] PHST- 2021/04/02 00:00 [received] PHST- 2021/08/14 00:00 [accepted] PHST- 2021/09/02 06:00 [pubmed] PHST- 2021/12/25 06:00 [medline] PHST- 2021/09/01 07:43 [entrez] AID - 10.1002/ptr.7265 [doi] PST - ppublish SO - Phytother Res. 2021 Dec;35(12):6802-6812. doi: 10.1002/ptr.7265. Epub 2021 Sep 1.